Results 241 to 250 of about 12,793,395 (292)
Bulletin du cancer, 1986 In order to ascertain the clinical usefulness of CA 19-9 in detecting pancreatic cancer in comparison with CEA, and to verify the influence of age and liver dysfunction on serum levels of these two antigens, serum CA 19-9 and CEA were assessed in 32 control subjects, 32 patients with pancreatic cancer, 26 with chronic pancreatitis and 43 with ...
DEL FAVERO, GIUSEPPE +8 more
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Need for Assay Harmonization: Carbohydrate Antigen 19-9 (CA 19-9) Assay Example
Turkish Society of Clinical Biochemistry, 2022Amaç: CA 19-9, yüksek riskli kişilerde pankreas, safra kanalı ve kolon kanserlerinin tespiti ve takibinde diğer testlerin tamamlayıcısı olarak yaygın kullanılan bir biyobelirteçtir. CA 19-9 testinin farklı yöntemlerle ölçüm sonuçları arasında uyumsuzluklar bulunabilmektedir. Bu çalışmanın amacı CA 19-9 testinin harmonizasyon problemini ortaya koymaktır.
Fatma Uçar +3 more
openaire +1 more source
Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9)
Clinical Chemistry and Laboratory Medicine (CCLM), 2006AbstractClin Chem Lab Med 2006;44:1137–9.
Mario, Berth +6 more
openaire +2 more sources
A case of bronchogenic cyst with high production of antigen CA 19–9
Cancer, 1989A 35-year-old man was hospitalized with complaints of retrosternal pain and high fever. A chest radiograph showed a large round mass in the mediastinum. Of the several tumor markers in the serum tested, only CA 19-9 was elevated. Thoracotomy revealed a cystic mass with purulent hemorrhagic materials.
A, Okubo +6 more
openaire +2 more sources
Scandinavian Journal of Gastroenterology, 1989
Serum levels of the new tumor-associated marker CA 72-4 were measured in healthy controls (n = 64) and patients with benign (n = 410) or malignant (n = 199) gastrointestinal diseases. A cut-off limit of 4 U/ml was established. Tumor-indicating sensitivity was compared with that of the conventional markers carcinoembryonic antigen (CEA) and CA 19-9.
G, Heptner, S, Domschke, W, Domschke
openaire +2 more sources
Serum levels of the new tumor-associated marker CA 72-4 were measured in healthy controls (n = 64) and patients with benign (n = 410) or malignant (n = 199) gastrointestinal diseases. A cut-off limit of 4 U/ml was established. Tumor-indicating sensitivity was compared with that of the conventional markers carcinoembryonic antigen (CEA) and CA 19-9.
G, Heptner, S, Domschke, W, Domschke
openaire +2 more sources
Expression of the carcinoma-associated antigens CA 19-9 and CA-50 in inflammatory bowel disease
Diseases of the Colon & Rectum, 1987The expression of gastrointestinal cancer antigen, CA 19-9, and of carcinoma-associated antigen, CA-50, was studied in formalin-fixed and paraffin-embedded tissue from 18 patients with ulcerative colitis, 29 with Crohn's disease in the colon, four with diverticular disease, and eight with sigmoid volvulus.
G, Frykholm +3 more
openaire +2 more sources
1995
This tumour-associated antigen is a high molecular weight mucin epitope expression is defined by a homologous monoclonal antibody system — the CA 19-9 antibody The antigenic epitope represents a sialylated Lewisa blood group pentasaccharide and, as such, is similar to that detected by some other monocloncal antibody systems.
openaire +1 more source
This tumour-associated antigen is a high molecular weight mucin epitope expression is defined by a homologous monoclonal antibody system — the CA 19-9 antibody The antigenic epitope represents a sialylated Lewisa blood group pentasaccharide and, as such, is similar to that detected by some other monocloncal antibody systems.
openaire +1 more source
American Journal of Obstetrics and Gynecology, 1984
CA 125 and CA 19-9 are antigenic determinants associated with human epithelial ovarian carcinomas. Murine monoclonal antibodies have been raised against these determinants, and immunoradiometric assays have been developed to monitor antigen levels in the serum of cancer patients. This study was undertaken to determine whether concomitant measurement of
R C, Bast +7 more
openaire +2 more sources
CA 125 and CA 19-9 are antigenic determinants associated with human epithelial ovarian carcinomas. Murine monoclonal antibodies have been raised against these determinants, and immunoradiometric assays have been developed to monitor antigen levels in the serum of cancer patients. This study was undertaken to determine whether concomitant measurement of
R C, Bast +7 more
openaire +2 more sources
The Japanese Journal of Surgery, 1986
The significance of measurement of serum CA 19-9 levels and the correlation between the serum levels of CA 19-9 and CEA in 61 patients with colorectal cancer were investigated. CA 19-9 levels above 37 U/ml were found in 24.6 per cent, while CEA levels above 5 ng/ml were observed in 34.4 per cent. Elevation of one or both of two antigens was found in 44.
H, Tomoda, M, Furusawa
openaire +2 more sources
The significance of measurement of serum CA 19-9 levels and the correlation between the serum levels of CA 19-9 and CEA in 61 patients with colorectal cancer were investigated. CA 19-9 levels above 37 U/ml were found in 24.6 per cent, while CEA levels above 5 ng/ml were observed in 34.4 per cent. Elevation of one or both of two antigens was found in 44.
H, Tomoda, M, Furusawa
openaire +2 more sources
Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma, 1986
CA 19-9, a new antigenic tumor marker for gastrointestinal tumors, has been assayed with Carcinoembriogenic antigen, in 90 healthy patients and 47 patients with gastric cancer (20) and colorectal cancer (27). A good specificity has been found for this antigen (97.7%). Its sensibility seems to be slightly superior to that of CEA. However the sensibility
E, Capocasale +4 more
openaire +1 more source
CA 19-9, a new antigenic tumor marker for gastrointestinal tumors, has been assayed with Carcinoembriogenic antigen, in 90 healthy patients and 47 patients with gastric cancer (20) and colorectal cancer (27). A good specificity has been found for this antigen (97.7%). Its sensibility seems to be slightly superior to that of CEA. However the sensibility
E, Capocasale +4 more
openaire +1 more source